Hemideina, a hearing solutions company focussed on the development and commercialisation of the Hera Wireless Implant, has successfully raised a Series A investment of $1 million in their first round of equity financing.

The fate of the federal government's proposed reforms to cut spending on the R&D Tax Incentive is unlikely to be resolved before the election.

Adelaide-based clinical-stage biopharmaceutical company Bionomics (ASX:BNO) has announced the details of an additional data analysis of a phase 2 trial of BNC210 that shows a statistically significant response in the treatment of PTSD symptoms.

The Australian Government has introduced the Global Talent Scheme as a niche pilot scheme for both established companies and start-ups under the Temporary Skill Shortage visa programme, with the aim to bring globally mobile, highly-skilled and specialised individuals to Australia.

The federal government has announced that a partnership between BioCurate, MTPConnect, UniQuest and the Medical Device Partnering Program, will operate the $22.3 million Biomedical Translation Bridge (BTB) Program.

The company said the highlight was the services business that grew revenue by 28 per cent with sound processor upgrade revenue increasing by 26 per cent in constant currency terms.

Creso Pharma (ASX:CPH) has announced that wholly-owned subsidiary, Mernova Medical, has been granted a license to cultivate by Health Canada.